Chelerythrine, a protein kinase C inhibitor, interacts with cyclic nucleotide phosphodiesterases

European Journal of Pharmacology

Volumn 324, Issue 1, 1997, Pages 85-88

  Eckly Michel, Anita E ^a   Le Bec, Alain ^a   Lugnier, Claire ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Chelerythrine; Cyclic nucleotide; Isoprenaline; Phosphodiesterase; Protein kinase C1; SK and F 94120; Vasorelaxation

Indexed keywords

5 (4 ACETAMIDOPHENYL) 2(1H) PYRAZINONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHELERYTHRINE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; ISOPRENALINE; PROTEIN KINASE C INHIBITOR;

ANIMAL TISSUE; AORTA; ARTICLE; CATTLE; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

ADRENERGIC BETA-AGONISTS; ALKALOIDS; ANIMALS; AORTA; BENZOPHENANTHRIDINES; CARDIOTONIC AGENTS; CATTLE; DRUG INTERACTIONS; DRUG SYNERGISM; ENZYME ACTIVATION; ENZYME INHIBITORS; GLYCOPROTEINS; HYDROLYSIS; ISOPROTERENOL; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; PHENANTHRIDINES; PROTEIN KINASE C; PYRAZINES; RATS; RATS, WISTAR;

EID: 0031564602     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00149-0     Document Type: Article

References (16)

1. Beavo J.A., Conti M., Heaslip R.J. Multiple cyclic nucleotide phosphodiesterases. Mol. Pharmacol. 46:1994;399-405.
2. Chen C.N., Denome S., Davis R.L. Molecular analysis of cDNA clones and the corresponding genomic coding sequences of the drosophila dunce+gene, the structural gene for cAMP phosphodiesterase. Proc. Natl. Acad. Sci. USA. 83:1986;9313-9317.
3. Eckly A.E., Lugnier C. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway. Br. J. Pharmacol. 113:1994;445-450.
4. Eckly A.E., Stoclet J.-C., Lugnier C. Isoprenaline induces endothelium-independent relaxation and accumulation of cyclic nucleotides in the rat aorta. Eur. J. Pharmacol. 271:1994;237-240.
5. Guillemain I., Rossignol B. Protein kinase C and phospholipase D activation in rat parotid glands. FEBS Lett. 363:1995;13-16.
6. Herbert J.M., Augereau J.M., Gleye J., Maffrand J.-P. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172:1990;993-999.
7. Jacobowitz O., Chen J., Premont R.T., Iyengar R. Stimulation of specific types of Gs-stimulated adenylyl cyclases by phorbol ester treatment. J. Biol. Chem. 268:1993;3829-3832.
8. 2+ channels by β-adrenergic agonists. Proc. Natl. Acad. Sci. USA. 93:1996;295-299.
9. Komas N., Lugnier C., Stoclet J.-C. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br. J. Pharmacol. 104:1991;495-503.
10. Lugnier C., Komas N. Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation. Eur. Heart J. 14(Suppl. 1):1993;141-148.
11. Lugnier C., Schini V. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells. Biochem. Pharmacol. 39:1990;75-84.
12. McKinney J.S., Rubin R.P. Enhancement of cyclic AMP modulated salivary amylase secretion by protein kinase C activators. Biochem. Pharmacol. 37:1988;4433-4438.
13. 2α stimulates cAMP phosphodiesterase via protein kinase C in cultured human granulosa cells. Mol. Cell. Endocrinol. 82:1991;207-214.
14. Ohno S., Kawasaki H., Imajoh S., Suzuki K., Inagaki M., Yokokura H., Sakoh T., Hidaka H. Tissue-specific expression of three distinct types of rabbit protein kinase C. Nature. 325:1987;161-166.
15. Palmer, T., 1985. Enzyme inhibition. In: Palmer, T., Wiseman, A. (Eds.), Understanding Enzymes, 2nd ed. Ellis Horwood, Chichester, pp. 142-169.
16. Yamamoto T., Yamamoto S., Osborne J.C. Jr., Manganiello V.C., Vaughan M., Hidaka H. Complex effects of inhibitors on cyclic GMP-stimulated cyclic nucleotide phosphodiesterase. J. Biol. Chem. 258:1983;14173-14177.